Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial

Ahmed Farah; Mohamed Elgarhy; Marc-Alexander Ohlow; Jochen Wohrle; Norman Mangner; Sven Möbius-Winkler; Marco Cattaneo; Nicole Gilgen; Bruno Scheller; Raban Jeger

doi:10.5114/aic.2022.118528

eISSN: 1897-4295
ISSN: 1734-9338

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2022
vol. 18

Send email

Copy url:

abstract:

Original paper

Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial

Ahmed Farah

¹

,

Mohamed Elgarhy

²

,

Marc-Alexander Ohlow

³

,

Jochen Wohrle

⁴

,

Norman Mangner

⁵

,

Sven Möbius-Winkler

⁶

,

Marco Cattaneo

⁷

,

Nicole Gilgen

⁷

,

Bruno Scheller

⁸

,

Raban Jeger

^{7, 9}

Knappschaftskrankenhaus, Westfalen-Clinic, Dortmund, Germany
Central Hospital, Bad Berka, Germany
SRH, Wald-Clinic, Gera, Germany
Medical Campus Lake Constance, Friedrichshafen, Germany
Herzzentrum Dresden, Technische Universität Dresden, Dresden, Germany
University Hospital Jena, Jena, Germany
University Hospital Basel, University of Basel, Basel, Switzerland
University Hospital Saarland, Homburg, Germany
Triemli Hospital Zürich, Switzerland

Adv Interv Cardiol 2022; 18, 2 (68): 122–130

DOI: https://doi.org/10.5114/aic.2022.118528

Online publish date: 2022/08/19

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Farah A, Elgarhy M, Ohlow M, et al. Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2022;18(2):122-130. doi:10.5114/aic.2022.118528.

APA

Farah, A., Elgarhy, M., Ohlow, M., Wohrle, J., Mangner, N.,  & Möbius-Winkler, S. et al. (2022). Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 18(2), 122-130. https://doi.org/10.5114/aic.2022.118528

Chicago

Farah, Ahmed, Mohamed Elgarhy, Marc-Alexander Ohlow, Jochen Wohrle, Norman Mangner, Sven Möbius-Winkler,  and Marco Cattaneo et al. 2022. "Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 18 (2): 122-130. doi:10.5114/aic.2022.118528.

Harvard

Farah, A., Elgarhy, M., Ohlow, M., Wohrle, J., Mangner, N., Möbius-Winkler, S., Cattaneo, M., Gilgen, N., Scheller, B.,  and Jeger, R. (2022). Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 18(2), pp.122-130. https://doi.org/10.5114/aic.2022.118528

MLA

Farah, Ahmed et al. "Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 18, no. 2, 2022, pp. 122-130. doi:10.5114/aic.2022.118528.

Vancouver

Farah A, Elgarhy M, Ohlow M, Wohrle J, Mangner N, Möbius-Winkler S et al. Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2022;18(2):122-130. doi:10.5114/aic.2022.118528.

Introduction
In BASKET-SMALL 2, drug-coated balloons (DCB) were non-inferior to drug-eluting stents (DES) in de-novo stenosis of small coronary vessels (≤ 2.75 mm) regarding clinical endpoints up to 36 months. Aim: In the present subgroup analysis, we aimed to analyze the effect of the two treatment strategies in different vessel sizes.

Material and methods
Patients were analyzed according to the size of the device used (small > 2.5 mm vs. very small ≤ 2.5 mm). The primary endpoint was major adverse cardiac events (MACE), while secondary endpoints were target vessel revascularization (TVR), non-fatal myocardial infarction, cardiac death, and all-cause mortality, all at 36 months. Interactions for the different groups were assessed with Cox regression analysis.

Results
Overall, 758 patients were enrolled in this analysis, of which 437 (58%) had very small vessel disease. There were similar results in both treatment groups for the primary endpoint in both small and very small vessels (DCB vs DES, MACE at 3 years in small vessels HR = 1.31, 95% CI: 0.74–2.32, p = 0.355, and very small vessels HR = 0.82, 95% CI: 0.49–1.39, p = 0.468). Second generation paclitaxel-eluting stents showed significantly higher rates for MACE (p = 0.041), TVR (p = 0.004) and non-fatal myocardial infarction (p = 0.036) compared to DCB in very small coronary arteries at 3 years, while results were similar in small coronary arteries.

Conclusions
Efficacy and safety of DCB are similar irrespective of vessel size. However, there is a beneficial effect of DCB over paclitaxel-eluting stents regarding TVR, non-fatal myocardial infarction and MACE that is most pronounced in very small coronary arteries.

keywords:

Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial

Ahmed Farah 1 , Mohamed Elgarhy 2 , Marc-Alexander Ohlow 3 , Jochen Wohrle 4 , Norman Mangner 5 , Sven Möbius-Winkler 6 , Marco Cattaneo 7 , Nicole Gilgen 7 , Bruno Scheller 8 , Raban Jeger 7, 9

small vessel disease, drug-coated balloon, drug-eluting stent, vessel size, paclitaxel

Ahmed Farah

¹

,

Mohamed Elgarhy

²

,

Marc-Alexander Ohlow

³

,

Jochen Wohrle

⁴

,

Norman Mangner

⁵

,

Sven Möbius-Winkler

⁶

,

Marco Cattaneo

⁷

,

Nicole Gilgen

⁷

,

Bruno Scheller

⁸

,

Raban Jeger

^{7, 9}